{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:52:57Z","timestamp":1791114777021,"version":"4.1.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2012,3,27]]},"DOI":"10.1212\/wnl.0b013e31824de293","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T20:13:09Z","timestamp":1332792789000},"page":"1009-1015","source":"Crossref","is-referenced-by-count":206,"title":["Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders [RETIRED]"],"prefix":"10.1212","volume":"78","author":[{"given":"H.S.","family":"Patwa","sequence":"first","affiliation":[{"name":"From the Yale University\/VA Connecticut Healthcare System (H.S.P.), New Haven, CT; Johns Hopkins Medical Institute (V.C.), Baltimore, MD; University of Toronto (H.K.), Toronto, Canada; Cleveland Clinic (A.D.R.-G.), Cleveland, OH; and Stanford University (Y.T.S.), Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"From the Yale University\/VA Connecticut Healthcare System (H.S.P.), New Haven, CT; Johns Hopkins Medical Institute (V.C.), Baltimore, MD; University of Toronto (H.K.), Toronto, Canada; Cleveland Clinic (A.D.R.-G.), Cleveland, OH; and Stanford University (Y.T.S.), Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Katzberg","sequence":"additional","affiliation":[{"name":"From the Yale University\/VA Connecticut Healthcare System (H.S.P.), New Haven, CT; Johns Hopkins Medical Institute (V.C.), Baltimore, MD; University of Toronto (H.K.), Toronto, Canada; Cleveland Clinic (A.D.R.-G.), Cleveland, OH; and Stanford University (Y.T.S.), Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Rae-Grant","sequence":"additional","affiliation":[{"name":"From the Yale University\/VA Connecticut Healthcare System (H.S.P.), New Haven, CT; Johns Hopkins Medical Institute (V.C.), Baltimore, MD; University of Toronto (H.K.), Toronto, Canada; Cleveland Clinic (A.D.R.-G.), Cleveland, OH; and Stanford University (Y.T.S.), Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.T.","family":"So","sequence":"additional","affiliation":[{"name":"From the Yale University\/VA Connecticut Healthcare System (H.S.P.), New Haven, CT; Johns Hopkins Medical Institute (V.C.), Baltimore, MD; University of Toronto (H.K.), Toronto, Canada; Cleveland Clinic (A.D.R.-G.), Cleveland, OH; and Stanford University (Y.T.S.), Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e31824de293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:04:00Z","timestamp":1711631040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e31824de293"}},"subtitle":["Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology"],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":0,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,3,27]]}},"alternative-id":["10.1212\/WNL.0b013e31824de293"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e31824de293","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}